Pharmacogenomic Germline Testing: Applications in Oncology Nursing

被引：0
|
作者：
Germany, Joshua [1 ]
Kueber, Janet [1 ]
机构：
[1] Prisma Hlth Canc Inst Greenville, Greenville, SC 29615 USA
来源：
CLINICAL JOURNAL OF ONCOLOGY NURSING | 2023年 / 27卷 / 02期
关键词：
pharmacogenomics; pharmacogenetics; germline testing; precision medicine; FUTURE;
D O I：
10.1188/23.CJON.129-133
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The implementation of pharmacogenomics in clinical practice has increased in clinical oncology practice. Pharmacogenomic germline testing can be used to develop and prescribe safer and more effective medications and treatment regimens that are personalized to patients based on their individual genetic profiles. To properly apply pharmacogenomics to oncology practice, nurses need to have a clear understanding of pharmacogenomics, specifically how to collect DNA specimens, interpret test results, and educate patients about lifelong implications. This article reviews pharmacogenomic germline testing, its use in oncology clinical practice, and how pharmacogenomics can help oncology nurses provide optimal care for patients.
引用
收藏
页码：129 / 133
页数：5
相关论文
共 50 条
  • [1] ANALYZING THE CLINICAL ACTIONABILITY OF GERMLINE PHARMACOGENOMIC (PGX) DATA IN ONCOLOGY (ONC).
    Wellmann, R.
    Danahey, K.
    Hussain, S.
    Ratain, M. J.
    O'Donnell, P. H.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S31 - S32
  • [2] Integrating pharmacogenomic testing into paired germline and somatic genomic testing in patients with cancer
    Seligson, Nathan D.
    Kolesar, Jill M.
    Alam, Benish
    Baker, Laura
    Lamba, Jatinder K.
    Fridley, Brooke L.
    Salahudeen, Ameen A.
    Hertz, Daniel L.
    Hicks, J. Kevin
    [J]. PHARMACOGENOMICS, 2023, 24 (13) : 731 - 738
  • [3] Knowledge and Attitudes of Oncology Nurses Regarding Pharmacogenomic Testing
    Dodson, Crystal
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2014, 18 (04) : E64 - E70
  • [4] POTENTIAL IMPACT OF PHARMACOGENOMIC (PGX) TESTING IN ONCOLOGY PATIENTS.
    Reizine, N.
    Danahey, K.
    Parsad, S.
    Ratain, M.
    O'Donnell, P.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S87 - S87
  • [5] POTENTIAL IMPACT OF PHARMACOGENOMIC (PGX) TESTING IN ONCOLOGY PATIENTS.
    Reizine, N.
    Danahey, K.
    Parsad, S.
    Ratain, M.
    O'Donnell, P.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S19 - S19
  • [6] Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology
    Shriver, Sharon P.
    Adams, Devon
    Mckelvey, Brittany Avin
    Mccune, Jeannine S.
    Miles, Dale
    Pratt, Victoria M.
    Ashcraft, Kristine
    Mcleod, Howard L.
    Williams, Hannah
    Fleury, Mark E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (10)
  • [7] Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectives
    Bhatt, Meghna
    Peshkin, Beth N.
    Kazi, Sadaf
    Schwartz, Marc D.
    Ashai, Nadia
    Swain, Sandra M.
    Smith, D. Max
    [J]. PHARMACOGENOMICS, 2023, 24 (16) : 859 - 870
  • [8] The Potential and Challenges of Expanded Germline Testing in Clinical Oncology
    Van Allen, Eliezer M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (09): : 801 - 803
  • [9] Economic Evaluation of Pharmacogenomic Testing in Pediatric Oncology Patients Treated With Anthracyclines
    Yan, K.
    Dionne, F.
    Rassekh, S.
    Ross, C.
    Carleton, B.
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 : S441 - S441
  • [10] Breaking Barriers: Integrating Germline Testing With Oncology Care
    Shastry, Mythili
    Hammer, Marilyn E.
    Mckenzie, Andrew J.
    Hamilton, Erika P.
    [J]. JCO ONCOLOGY PRACTICE, 2024, 20 (02)
12345